James Lindsay is Professor of Inflammatory Bowel Disease and a Consultant Gastroenterologist. He studied medicine at the Universities of Cambridge and Oxford and qualified in 1993. He completed his PhD in mucosal immunology at Imperial College London. His NHS base is Barts Health NHS Trust and he also holds an academic position at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. He Leads the adolescent and adult IBD service at The Royal London Hospital as well as a private clinic at the London Digestive Centre which has a dedicated IBD MDT meeting to discuss complex cases. He performs endoscopy and colonoscopy at the Princess Grace Hospital and is a Bowel Cancer Screening colonoscopist. He is the past Education Officer and member of the Governing Board of the European Crohn’s and Colitis Organisation (ECCO). He has chaired working groups for the ECCO consensus on the management of Crohn’s disease and ulcerative colitis. He is a member of the prestigious International Organisation of IBD (IOIBD). Professor Lindsay serves on the BSG IBD Clinical Trials Steering Group. He is Chief Investigator for a series of investigator-led and commercial clinical trials in IBD. He leads the NIHR funded ASTIClite trial which will assess the efficacy, safety and mechanism of action of low intensity autologous stem cell transplantation in patients with refractory Crohn’s disease. In addition, he leads a program of translational science research.